A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
Clinical trial NCT06423703 · COMPLETED
Trial details
- NCT number
- NCT06423703
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2025-01-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.